Characterization of patients with autoimmune hepatitis at an university hospital in Medellín-Colombia: cohort study

• Published in: Gastroenterología y hepatología Vol. 41; no. 2; p. 87
• Main Authors: Díaz-Ramírez, Gabriel Sebastián, Marín-Zuluaga, Juan Ignacio, Donado-Gómez, Jorge Hernando, Muñoz-Maya, Octavio, Santos-Sánchez, Óscar, Restrepo-Gutiérrez, Juan Carlos
• Format: Journal Article
• Language: English; Spanish
• Published: Spain 01.02.2018
• Subjects: Hepatitis autoinmune; Inmunosupresores; Cirrosis hepática; Immunosuppressive; Latinoamérica; Autoimmune hepatitis; Liver cirrhosis; Latin America; Liver transplantation; Trasplante de hígado
• ISSN: 0210-5705
• DOI: 10.1016/j.gastrohep.2017.09.003

Autoimmune hepatitis is a chronic liver disease that impacts on morbidity and mortality of patients. Few epidemiological data exist of this in Latin America and Colombia. The aim of this study is to describe the demographic, clinical and laboratory characteristics of the patients; the treatment and the response to it, the evolution and course of the disease, requirement of liver transplantation and mortality. Historical cohort study that include patients attended at an University Hospital in Medellin, Colombia between January 2010 and December 2016 with ≥16 years age at the time of diagnosis of autoimmune hepatitis. Data collection was done from the review of medical records. Statistical analysis was performed using SPSS version 20. The study included 278 patients, 90% of the patients were women, the median age at diagnosis was 50 years. 37.8% were cirrhotic at the time of diagnosis. The biochemical remission was 85%. In patients who developed cirrhosis it was found a higher proportion of men (21.2 vs. 7.8%, p=.027), a greater frequency of overlap autoimmune-primary sclerosant cholangitis (6.0 vs. 0% p=.006) and a greater frequency of non-response to treatment (12.1 vs. 1.6%, p=.004). Autoimmune hepatitis is not a rare disease in Colombian population; it predominates in women but has a less favourable course in men. An important number of patients are cirrhotic at the time of diagnosis, the response to treatment and complications in our population are similar to those described worldwide.